| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/23/2000 | CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 03/22/2000 | EP0987552A2 Diarylsulfonylurea binding proteins |
| 03/22/2000 | EP0987274A1 Factor VIIa Inhibitors |
| 03/22/2000 | EP0987265A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/22/2000 | EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid |
| 03/22/2000 | EP0987248A1 Amide derivatives and their therapeutic use |
| 03/22/2000 | EP0987023A1 Transition metal complexes of non steroidal anti-inflammatory drugs |
| 03/22/2000 | EP0986561A1 Compounds for inhibition of ceramide-mediated signal transduction |
| 03/22/2000 | EP0986530A1 Indane compounds and their pharmaceutical use |
| 03/22/2000 | EP0986400A1 Integrin ligand, human mindin |
| 03/22/2000 | CN1248177A Coated particles, method of making and using |
| 03/22/2000 | CN1248165A Nimesulide gel system for topical use |
| 03/22/2000 | CN1247761A Rheumatism treating medicine |
| 03/21/2000 | US6040451 Used as analgesic, sedative and anaesthetic agents |
| 03/21/2000 | US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base |
| 03/21/2000 | US6040444 Process for preparing furan nitrone compounds |
| 03/21/2000 | US6040343 Remedy for keratoconjunctival diseases |
| 03/21/2000 | US6040341 Compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 03/21/2000 | US6040329 Substituted indazole analogs |
| 03/21/2000 | US6040327 Benzimidazole, benzoxazole and benzothiazole compounds |
| 03/21/2000 | US6040324 Prophylactic or therapeutic drug for renal diseases |
| 03/21/2000 | US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases |
| 03/21/2000 | US6040320 Antiinflammatory agent for treating diseases associated with overproduction of inflammatory cytokines, such as rheumatoid arthritis, inflammatory bowel disease, septic shock, osteoporosis, and osteoarthritis |
| 03/21/2000 | US6040319 cyclization; synthesis of cyclooxygenase-2 (COX) inhibitors such as etoricoxib |
| 03/21/2000 | US6040311 Treating bone disorders for preventing osteoporosis or inhibiting bone resorption in a mammal; treating tumor growth in a mammal |
| 03/21/2000 | US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 03/21/2000 | US6040302 1,4-disubstituted piperazines |
| 03/21/2000 | US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides |
| 03/21/2000 | US6040133 D-enzyme compositions and methods of their use |
| 03/21/2000 | US6039955 Plant extracts as antiinflammatory agents |
| 03/21/2000 | US6039949 Plant extracts obtained by filtration, centrifuging and dialysis |
| 03/21/2000 | CA2146097C 1h-indole-3-glyoxylamide spla2 inhibitors |
| 03/21/2000 | CA2132745C Novel cardioprotective agents |
| 03/16/2000 | WO2000014262A2 Methylation of plasmid vectors |
| 03/16/2000 | WO2000014235A1 Kunitz domain polypeptide zkun6 |
| 03/16/2000 | WO2000014230A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 03/16/2000 | WO2000014222A2 GABAB RECEPTOR SUBTYPES GABAB-R1c AND GABAB-R2 AND HETERODIMERS THEREOF |
| 03/16/2000 | WO2000014086A1 Chemokine receptor antagonists and methods of use therefor |
| 03/16/2000 | WO2000014083A1 SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO |
| 03/16/2000 | WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 03/16/2000 | WO2000013712A2 Methods and compositions for the prevention or treatment of cancer |
| 03/16/2000 | WO2000013684A2 Pharmaceutical composition and method for treatment of inflammation |
| 03/16/2000 | WO2000013672A1 New solid dose form of nanoparticulate naproxen |
| 03/16/2000 | WO2000013660A1 Lipid extract of the skeletonema algae |
| 03/16/2000 | WO2000013648A2 Method for the preparation of citalopram |
| 03/16/2000 | WO2000000209A3 Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions |
| 03/16/2000 | WO1999050403A9 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 03/16/2000 | CA2342882A1 Chemokine receptor antagonists and methods of use therefor |
| 03/16/2000 | CA2342284A1 Methylation of plasmid vectors |
| 03/16/2000 | CA2341752A1 Methods and compositions for the prevention or treatment of cancer |
| 03/16/2000 | CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 03/15/2000 | EP0985666A1 Substituted indole compounds as COX-2 inhibitors |
| 03/15/2000 | EP0985046A1 A soluble vaccinia virus protein that binds chemokines |
| 03/15/2000 | EP0985038A1 Sodium channel receptor |
| 03/15/2000 | EP0985036A1 Zinc ring protein |
| 03/15/2000 | EP0985030A2 New human ribonuclease |
| 03/15/2000 | EP0984981A1 Anti-inflammatory tyrosine derivatives |
| 03/15/2000 | EP0984970A1 Spiro-quinuclidine derivatives, their preparation and use |
| 03/15/2000 | EP0984966A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS |
| 03/15/2000 | EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 03/15/2000 | EP0984963A1 Novel compounds |
| 03/15/2000 | EP0984961A1 Novel pyridine derivatives and pharmaceutical compositions containing them |
| 03/15/2000 | EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/15/2000 | EP0984955A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNF$g(a) LEVELS |
| 03/15/2000 | EP0984943A1 Azacyclooctane and heptane derivatives, their preparation and usein therapy |
| 03/15/2000 | EP0984692A1 Novel angiogenesis inhibitors |
| 03/15/2000 | EP0850232B1 Benzothiazolone derivatives |
| 03/15/2000 | EP0783504B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE AS ANTAGONISTS OF AMPA-RECEPTORS |
| 03/15/2000 | EP0656008B1 Thrombin receptor antagonists |
| 03/15/2000 | EP0649468B1 Soluble cr1 derivatives |
| 03/15/2000 | EP0633787B1 Use of ibuprofen-beta-cyclodextrin complex for oral consumption |
| 03/15/2000 | EP0567566B1 Methods for treating tumor necrosis factor mediated diseases |
| 03/15/2000 | EP0533703B1 Use of steroids for the inhibition of angiogenesis |
| 03/15/2000 | EP0506785B1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
| 03/15/2000 | CN1247191A Imidazolium compound as synthetic material of imidazole lipoxidase inhibitor |
| 03/15/2000 | CN1247086A Process for making medical wine for treating rheumatism |
| 03/15/2000 | CN1050297C Chinese herbal medicine compsn. for preparing non-dependence anti-cancer pain-alleviating drug and prepn. thereof |
| 03/15/2000 | CN1050283C Gel-type cosmetic composite |
| 03/14/2000 | US6037488 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
| 03/14/2000 | US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis |
| 03/14/2000 | US6037470 Purine compounds having PDE IV inhibitory activity and methods of synthesis |
| 03/14/2000 | US6037467 Methods for preparing carbohydrate-containing hydrophilic polymers |
| 03/14/2000 | US6037377 Antiinflammatory agents and antiallergens |
| 03/14/2000 | US6037363 Respiratory system disorders, cystic fibrosis |
| 03/14/2000 | US6037355 Imidazole lipoxygenase inhibitors |
| 03/14/2000 | US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues |
| 03/14/2000 | US6036975 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 03/14/2000 | US6036956 Method and dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease |
| 03/14/2000 | CA2123593C Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 03/14/2000 | CA2013188C Preservative system for ophthalmic formulations |
| 03/14/2000 | CA2008263C Pyrazolopyridine compound and processes for preparation thereof |
| 03/09/2000 | WO2000013015A1 Modulating multiple lineage kinase proteins |
| 03/09/2000 | WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 03/09/2000 | WO2000012720A2 Elongase genes and uses thereof |
| 03/09/2000 | WO2000012703A2 Protein transport-associated molecules |
| 03/09/2000 | WO2000012514A1 Novel compounds |
| 03/09/2000 | WO2000012512A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 03/09/2000 | WO2000012497A2 Quinazoline derivatives as medicaments |
| 03/09/2000 | WO2000012489A1 1, 2, 4-triazole-3-thione compounds |
| 03/09/2000 | WO2000012485A1 Pyrimidine compounds |